New drug shows promise for Hard-to-Treat breast cancer
NCT ID NCT05596409
First seen Apr 25, 2026 · Last updated May 24, 2026 · Updated 4 times
Summary
This study tests a new oral drug called elacestrant in 61 people with a common type of advanced breast cancer (ER+/HER2-). Participants have not received a specific class of targeted therapy (CDK4/6 inhibitors) before. The main goal is to see how long the drug can control cancer growth and how safe it is over 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
COMPLEX ONCOLOGICAL CENTER - Shumen
Shumen, 9700, Bulgaria
-
Centro De Pesquisa Clinica DO Hospital Sirio-Libanes - UNIDADE Brasilia
Brasília, 70200-730, Brazil
-
Centro de Estudos e Pesquisas de Hematologia e Oncologia- CEPHO
Santo André, São Paulo, 09060-650, Brazil
-
Centro de Pesquisas Clinicas em Oncologia (Center for Clinical Research in Oncology (CPCO)) - Hospital Evangélico de Cachoeiro de Itapemirim
Cachoeiro de Itapemirim, Espírito Santo, 29308-014, Brazil
-
Centro de Pesquisas Oncologicas
Florianópolis, Santa Catarina, 88034-000, Brazil
-
Clinica de Pesquisas e Centro de Estudos Em Oncologia Ginecologica e Mamaria Ltda
São Paulo, 01317-001, Brazil
-
Complex Oncology Center
Plovdiv, 4000, Bulgaria
-
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, 89128, United States
-
Fucam, Ac.
Mexico City, 4980, Mexico
-
Highlands Oncology Group, PA
Springdale, Arkansas, 72762, United States
-
Hospital São Lucas PUCRS - Centro de Pesquisa em Oncologia (CPO)
Porto Alegre, Rio Granda Do Sul, 70200-730, Brazil
-
Hospital de Amor de Barretos
Barretos, São Paulo, 14784-400, Brazil
-
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Granda Do Sul, 90035, Brazil
-
I CAN Oncology Center, Centro Medico AVE
Monterrey, Nuevo León, 64710, Mexico
-
Innova Medical Center
Tbilisi, 179, Georgia
-
Institute of Clinical Oncology
Tbilisi, Georgia
-
Institutul Oncologic "Prof. Dr. Ion Chiricuta" Cluj Napoca
Cluj-Napoca, Cluj, 400150, Romania
-
LTD Simon Khechinashvili University Clinic
Tbilisi, 179, Georgia
-
Northwestern University, Northwestern Feinberg School of Medicine Prentice Women's Hospital
Chicago, Illinois, 60611, United States
-
Torre Medica Hospital Dalinde
Mexico City, 06760, Mexico
-
UT Health San Antonio Mays Cancer Center
San Antonio, Texas, 78229, United States
-
Unidad Médica Onco-Hematológica
Puebla City, 4515, Mexico
Conditions
Explore the condition pages connected to this study.